- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT05860959
SUBLOCADE 장기 성과
오피오이드 사용 장애(오피오이드 의존성)가 있는 성인의 SUBLOCADE(SUBUTEX 서방형) 임상 결과에 대한 4상 종단 연구
This study will provide the opportunity to generate data on the long-term use of SUBLOCADE under real-world conditions, and to observe enduring changes in lifestyle, health, and sociodemographic factors that are part of the recovery process. Long-term patterns of abstinence/opioid misuse as well as measures of participants' physical, psychological, social, and economic well-being will be monitored to better understand factors associated with recovery from opioid use disorder (OUD). Therefore, this study will observe participants up to a maximum of 4 years.
연구 개요
상태
정황
상세 설명
This is a Phase IV, prospective, multicentre, multinational, open-label, real-world observational study in participants with current or a history of OUD/opioid dependence.
연구 유형
등록 (실제)
연락처 및 위치
연구 장소
-
-
California
-
Costa Mesa, California, 미국, 92626
- ATP Clinical Research
-
Escondido, California, 미국, 92025
- Neighborhood Healthcare-Institute of Health
-
-
Connecticut
-
Westport, Connecticut, 미국, 06880
- Elevate Health and Wellness
-
-
Florida
-
Hialeah, Florida, 미국, 33012
- United Research Institute
-
Hollywood, Florida, 미국, 33021
- Zenith Clinical Research LLC
-
Miami, Florida, 미국, 33126
- Jackson Health Community Center
-
Miami, Florida, 미국, 33134
- G+C Research Group
-
-
Georgia
-
Decatur, Georgia, 미국, 30033-4004
- Atlanta VA Medical Center
-
-
Kansas
-
Kansas City, Kansas, 미국, 66160
- University of Kansas Medical Center
-
Prairie Village, Kansas, 미국, 66210
- Collective Medical Research.
-
-
Maine
-
Scarborough, Maine, 미국, 04074-7163
- Maine Health
-
-
Maryland
-
Baltimore, Maryland, 미국, 21229
- Maryland Treatment Centers
-
-
Massachusetts
-
Springfield, Massachusetts, 미국, 01199
- Baystate Health
-
-
Michigan
-
Dearborn, Michigan, 미국, 48124
- THRYV Clinical Studies
-
Dearborn Heights, Michigan, 미국, 48127
- Vida Clinical Studies
-
Detroit, Michigan, 미국, 48201
- Wayne State University Hospital
-
Fair Haven, Michigan, 미국, 48023
- North Point Medical Center
-
Grand Rapids, Michigan, 미국, 49503-4224
- SHMG Center for Integrative Medicine
-
-
Mississippi
-
Tupelo, Mississippi, 미국, 38801
- North Mississippi Medical Center
-
-
Missouri
-
St Louis, Missouri, 미국, 63141-8704
- Psych Care Consultants
-
-
New York
-
Amherst, New York, 미국, 14226
- DENT Neurologic Institute
-
Binghamton, New York, 미국, 13903
- United Health Services
-
New York, New York, 미국, 10029
- Icahn School of Medicine at Mount Sinai
-
North New Hyde Park, New York, 미국, 11042
- Core Clinical Trials
-
Rockville Centre, New York, 미국, 11570
- Stuart Wasser Practice
-
-
North Carolina
-
Charlotte, North Carolina, 미국, 28277
- Onsite Clinical Solutions LLC
-
-
Oklahoma
-
Oklahoma City, Oklahoma, 미국, 73112
- Pahl Pharmaceutical Professionals LLC
-
-
Oregon
-
Corvallis, Oregon, 미국, 97330
- Healing Comfort Clinic, LLC
-
-
Pennsylvania
-
Narberth, Pennsylvania, 미국, 19072
- Thalia Medical Centre
-
-
South Carolina
-
Charleston, South Carolina, 미국, 29407
- Charleston Pain and Rehabilitation Center
-
Columbia, South Carolina, 미국, 29205
- Midlands Neurology
-
Greenville, South Carolina, 미국, 29605
- Prisma Health
-
-
Texas
-
Houston, Texas, 미국, 77043
- Biopharma Informatic, Inc. Research Center
-
-
Utah
-
Clinton, Utah, 미국, 84015
- Alpine Research Organization
-
-
Virginia
-
Richmond, Virginia, 미국, 23219
- Virginia Commonwealth University
-
-
-
-
-
Linköping, 스웨덴, 58185
- Linkoping University Hospital, Psychiatry Center
-
Stockholm, 스웨덴, SE-11365
- Beroendecentrum
-
-
-
-
Alberta
-
Calgary, Alberta, 캐나다, T2E2R2
- Smart Clinic
-
Edmonton, Alberta, 캐나다, T5J 3E4
- Recovery Alberta
-
-
British Columbia
-
Surrey, British Columbia, 캐나다, V3T 0H1
- Fraser Health Authority
-
-
Ontario
-
Burlington, Ontario, 캐나다, L7M 4X9
- Dr. J.S. Dhillon Medicine Prof. Corp
-
Hamilton, Ontario, 캐나다, L8N 1H3
- The Stipley Clinic
-
Owen Sound, Ontario, 캐나다, N4K 6M9
- Brightshores Health System
-
Sarnia, Ontario, 캐나다, N7T 5W9
- Bluewater Rapid Assessment Addiction Medicine Clinic
-
Toronto, Ontario, 캐나다, M4J 1M3
- Comprehensive Treatment Clinic
-
-
-
-
-
Richmond, 호주, VIC 3121
- Turning Point
-
-
Melbourne
-
Fitzroy, Melbourne, 호주, 3065
- St Vincent's Hospital Melbourne
-
-
New South Wales
-
Newcastle, New South Wales, 호주, 2300
- John Hunter Hospital
-
-
South Australia
-
Stepney, South Australia, 호주, 5069
- Drug and Alcohol Services South Australia (DASSA)
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
Participants may enroll if they have initiated treatment with SUBLOCADE within 3 months prior to signing the informed consent form (ICF), or have completed an Indivior SUBLOCADE study (eg, INDV-6000-401, INDV-6000-405) and received their last dose of SUBLOCADE on the study within 3 months prior to signing the ICF, and plan to receive additional SUBLOCADE injections.
설명
Inclusion Criteria:
Participants must meet all of the following criteria:
-
Is an adult ≥ 18 years of age who has signed the informed consent form
-
Plans to receive additional SUBLOCADE injections and
-
Has initiated treatment for OUD/opioid dependence with SUBLOCADE within the last 3 months prior to Baseline Visit
- OR
-
Has completed an Indivior SUBLOCADE study (eg, INDV-6000-401, INDV-6000-405) and has received the last dose of SUBLOCADE on that study within 3 months prior to Baseline Visit
-
-
Is not currently participating in any clinical trial requiring medical intervention
-
Is not currently using opioids to treat a diagnosis other than OUD/opioid dependence
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 관찰 모델: COHORT
- 시간 관점: PROSPECTIVE
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Participants achieving DSM-5 remission, early or sustained, (yes/no) while on initial SUBLOCADE treatment by 6 months and 1, 1.5, 2, 2.5, and 3 years from study Baseline
기간: up to a maximum of 4 years
|
|
up to a maximum of 4 years
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Key Secondary: Participants with "no symptoms" or improving by ≥1 DSM-5 severity classification within the last 3 months (moderate to mild, or severe to mild or moderate) relative to study Baseline (yes/no) at Month 6 and Years 1, 2, and 3
기간: up to a maximum of 4 years
|
DSM-5-Related |
up to a maximum of 4 years
|
|
Among those starting SUBLOCADE within 3 months of study Baseline, time to achieve early remission for the first time while on initial SUBLOCADE treatment
기간: up to a maximum of 4 years
|
DSM-5-Related |
up to a maximum of 4 years
|
|
Participants achieving DSM-5 sustained remission (yes/no) by 1, 1.5, 2, 2.5, and 3 years while on initial SUBLOCADE treatment
기간: up to a maximum of 4 years
|
DSM-5-Related |
up to a maximum of 4 years
|
|
Time to achieve sustained remission for the first time while on initial SUBLOCADE treatment
기간: up to a maximum of 4 years
|
DSM-5-Related |
up to a maximum of 4 years
|
|
Time to discontinuing initial SUBLOCADE treatment and the corresponding reasons for discontinuation, eg, resolution of OUD symptoms, safety concerns, treatment failure, or seeking alternative MOUD treatment
기간: up to a maximum of 4 years
|
MOUD Use and Retention |
up to a maximum of 4 years
|
|
Participants switching from initial SUBLOCADE treatment to another MOUD (yes/no), and the corresponding reasons, eg, safety concerns, treatment failure, seeking alternative MOUD treatment
기간: up to a maximum of 4 years
|
MOUD Use and Retention |
up to a maximum of 4 years
|
|
The overall treatment duration for participants who stop initial SUBLOCADE treatment as the result of resolution of OUD symptoms
기간: up to a maximum of 4 years
|
MOUD Use and Retention |
up to a maximum of 4 years
|
|
Participants with any positive opioid use in the past month (yes/no) at Month 6 and Years 1, 2, and 3 while on initial SUBLOCADE treatment
기간: up to a maximum of 4 years
|
Illicit Opioid Use (Self-Reports) |
up to a maximum of 4 years
|
|
Participants with opioid overdose requiring intervention (yes/no) while on initial SUBLOCADE treatment at least once during the first 6 months, and during Years 1, 2, and 3
기간: up to a maximum of 4 years
|
Opioid Overdose Requiring Intervention |
up to a maximum of 4 years
|
공동 작업자 및 조사자
스폰서
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- INDV-6000-406
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .